{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T17:12:24Z","timestamp":1778433144527,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2019xkj057"],"award-info":[{"award-number":["2019xkj057"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023AH050674"],"award-info":[{"award-number":["2023AH050674"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29159","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T16:13:36Z","timestamp":1712938416000},"page":"e29159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel GSK3\u03b2 inhibitor 5n attenuates acute kidney injury"],"prefix":"10.1016","volume":"10","author":[{"given":"Yu-ting","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e29159_bib1","doi-asserted-by":"crossref","first-page":"ITC66","DOI":"10.7326\/AITC201711070","article-title":"Acute kidney injury","volume":"167","author":"Levey","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e29159_bib2","article-title":"Acute kidney injury: biomarker-guided diagnosis and management","volume":"58","author":"Yoon","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.heliyon.2024.e29159_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061704","article-title":"Acute kidney injury: from diagnosis to prevention and treatment strategies","volume":"9","author":"Gameiro","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2024.e29159_bib5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40620-020-00793-2","article-title":"AKI: an increasingly recognized risk factor for CKD development and progression","volume":"33","author":"Kurzhagen","year":"2020","journal-title":"J. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2017.11.021","article-title":"Management of acute kidney injury: core curriculum 2018","volume":"72","author":"Moore","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.heliyon.2024.e29159_bib7","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(17)31329-6","article-title":"Management of patients at risk of acute kidney injury","volume":"389","author":"Vanmassenhove","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e29159_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12929-019-0518-9","article-title":"Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity","volume":"26","author":"Volarevic","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.heliyon.2024.e29159_bib9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1681\/ASN.2020101455","article-title":"Potential therapeutic targets for cisplatin-induced kidney injury: lessons from other models of AKI and fibrosis","volume":"32","author":"Sears","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/14656566.2022.2050214","article-title":"Advances in pharmacotherapy for acute kidney injury","volume":"23","author":"Xu","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.heliyon.2024.e29159_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155885","article-title":"GSK3beta and the aging kidney","volume":"132","author":"Kreidberg","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e29159_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.heliyon.2024.e29159_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040820","article-title":"GSK3: a kinase balancing promotion and resolution of inflammation","volume":"9","author":"Hoffmeister","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e29159_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/cas.14271","article-title":"Glycogen synthase kinase 3beta as a potential therapeutic target in synovial sarcoma and fibrosarcoma","volume":"111","author":"Abe","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.heliyon.2024.e29159_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41419-021-03709-5","article-title":"Permissive effect of GSK3beta on profibrogenic plasticity of renal tubular cells in progressive chronic kidney disease","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e29159_bib16","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ki.2014.427","article-title":"Glycogen synthase kinase-3beta promotes cyst expansion in polycystic kidney disease","volume":"87","author":"Tao","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e29159_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112874","article-title":"Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3beta inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents","volume":"209","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e29159_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-010715-103715","article-title":"The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies","volume":"56","author":"Martinez Molina","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib19","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.bbamcr.2016.08.004","article-title":"HGF alleviates high glucose-induced injury in podocytes by GSK3beta inhibition and autophagy restoration","volume":"1863","author":"Zhang","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.heliyon.2024.e29159_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2013.04.022","article-title":"Activator or inhibitor? GSK-3 as a new drug target","volume":"86","author":"Takahashi-Yanaga","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e29159_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e29159_bib23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.redox.2017.10.010","article-title":"Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy","volume":"14","author":"Cuadrado","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.pharep.2017.04.003","article-title":"Therapeutic molecules against type 2 diabetes: what we have and what are we expecting?","volume":"69","author":"Kumar","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.heliyon.2024.e29159_bib25","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1111\/jcmm.13274","article-title":"GSK-3beta activation index is a potential indicator for recurrent inflammation of chronic rhinosinusitis without nasal polyps","volume":"21","author":"Hong","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e29159_bib26","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10557.1","article-title":"Recent advances in understanding the cellular roles of GSK-3","volume":"6","author":"Cormier","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.heliyon.2024.e29159_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/labinvest.2010.142","article-title":"Conditional ablation of glycogen synthase kinase 3beta in postnatal mouse kidney","volume":"91","author":"Ge","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2024.e29159_bib28","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1681\/ASN.2015050565","article-title":"Genetic and pharmacologic targeting of glycogen synthase kinase 3beta reinforces the Nrf2 antioxidant defense against podocytopathy","volume":"27","author":"Zhou","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1681\/ASN.2013040350","article-title":"Delayed administration of a single dose of lithium promotes recovery from AKI","volume":"25","author":"Bao","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ki.2012.239","article-title":"Specific deletion of glycogen synthase kinase-3beta in the renal proximal tubule protects against acute nephrotoxic injury in mice","volume":"82","author":"Howard","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e29159_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.kint.2019.08.036","article-title":"Glycogen synthase kinase 3beta hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease","volume":"97","author":"Liang","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e29159_bib32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1074\/jbc.M114.593830","article-title":"Glycogen synthase kinase 3beta orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion","volume":"290","author":"Xu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e29159_bib33","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bph.12952","article-title":"Pharmacological targeting of GSK3beta confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141848","article-title":"Age-related GSK3beta overexpression drives podocyte senescence and glomerular aging","volume":"132","author":"Fang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e29159_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000509354","article-title":"Glycogen synthase kinase-3 signaling in acute kidney injury","volume":"144","author":"Jamadar","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.heliyon.2024.e29159_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.amjoto.2018.03.005","article-title":"Detection of GSK-3beta activation index in pediatric chronic tonsillitis is an indicator for chronic recurrent inflammation","volume":"39","author":"Gao","year":"2018","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib37","first-page":"611","article-title":"Effect of acetazolamide on lithium reabsorption and lithium-induced GSK3beta phosphorylation in rat kidney","volume":"74","author":"Uwai","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.heliyon.2024.e29159_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ccell.2019.03.004","article-title":"Synthetic lethality of wnt pathway activation and asparaginase in drug-resistant acute leukemias","volume":"35","author":"Hinze","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2024.e29159_bib39","doi-asserted-by":"crossref","first-page":"10731","DOI":"10.1074\/jbc.RA117.001298","article-title":"Glycogen synthase kinase-3 (GSK-3) activity regulates mRNA methylation in mouse embryonic stem cells","volume":"293","author":"Faulds","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e29159_bib40","first-page":"3561","article-title":"Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas","volume":"27","author":"Zheng","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2024.e29159_bib41","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1096\/fj.202000526RR","article-title":"Glycogen synthase kinase-3beta inhibits tubular regeneration in acute kidney injury by a FoxM1-dependent mechanism","volume":"34","author":"Sinha","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.heliyon.2024.e29159_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113181","article-title":"PLK2 targets GSK3beta to protect against cisplatin-induced acute kidney injury","volume":"417","author":"Wei","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.heliyon.2024.e29159_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.redox.2017.03.001","article-title":"Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK\/GSK3beta-Nrf2 signal axis","volume":"12","author":"Lv","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12974-019-1406-7","article-title":"Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK\/GSK-3beta\/Nrf2 signaling","volume":"16","author":"Duan","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e29159_bib45","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/01.CCM.0000178350.21839.44","article-title":"GSK-3beta inhibitors attenuate the organ injury\/dysfunction caused by endotoxemia in the rat","volume":"33","author":"Dugo","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.heliyon.2024.e29159_bib46","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3892\/mmr.2014.2650","article-title":"Inhibition of glycogen synthase kinase-3beta attenuates acute kidney injury in sodium taurocholate-induced severe acute pancreatitis in rats","volume":"10","author":"Zhao","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e29159_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cbdd.13781","article-title":"Anti-renal interstitial fibrosis effect of norcantharidin is exerted through inhibition of PP2Ac-mediated C-terminal phosphorylation of Smad3","volume":"97","author":"Luo","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.heliyon.2024.e29159_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jcp.24142","article-title":"Retinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-kappaB signaling pathway","volume":"228","author":"Nizamutdinova","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib49","doi-asserted-by":"crossref","first-page":"21341","DOI":"10.1074\/jbc.M110.104224","article-title":"Protein phosphatase 2A acts as a mitogen-activated protein kinase kinase kinase 3 (MEKK3) phosphatase to inhibit lysophosphatidic acid-induced IkappaB kinase beta\/nuclear factor-kappaB activation","volume":"285","author":"Sun","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e29159_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1752-0509-3-71","article-title":"Mechanism of PP2A-mediated IKK beta dephosphorylation: a systems biological approach","volume":"3","author":"Witt","year":"2009","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.heliyon.2024.e29159_bib51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1432-1033.1995.tb20491.x","article-title":"Activation of protein kinases and the inactivation of protein phosphatase 2A in tumour necrosis factor and interleukin-1 signal-transduction pathways","volume":"229","author":"Guy","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.heliyon.2024.e29159_bib52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2006.10.015","article-title":"RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling","volume":"24","author":"Li","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.heliyon.2024.e29159_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166740","article-title":"Atorvastatin alleviates experimental diabetic cardiomyopathy by regulating the GSK-3beta-PP2Ac-NF-kappaB signaling Axis","volume":"11","author":"Ren","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e29159_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BJ20110347","article-title":"Glycogen synthase kinase-3beta regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src","volume":"437","author":"Yao","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.heliyon.2024.e29159_bib55","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.neurobiolaging.2007.03.012","article-title":"Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms","volume":"29","author":"Liu","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2024.e29159_bib56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tibs.2016.10.009","article-title":"Stressed and inflamed, can GSK3 Be blamed?","volume":"42","author":"Jope","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.heliyon.2024.e29159_bib57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.heliyon.2024.e29159_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbior.2017.05.005","article-title":"Regulation of GSK-3 activity by curcumin, berberine and resveratrol: potential effects on multiple diseases","volume":"65","author":"McCubrey","year":"2017","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.heliyon.2024.e29159_bib59","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","article-title":"Molecular pathways: revisiting glycogen synthase kinase-3beta as a target for the treatment of cancer","volume":"23","author":"Walz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e29159_bib60","doi-asserted-by":"crossref","first-page":"S547","DOI":"10.3233\/JAD-179934","article-title":"The conundrum of GSK3 inhibitors: is it the dawn of a new beginning?","volume":"64","author":"Bhat","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e29159_bib61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.heliyon.2024.e29159_bib62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2017.07.058","article-title":"Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease","volume":"139","author":"De Simone","year":"2017","journal-title":"Eur. J. Med. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024051909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024051909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:42:18Z","timestamp":1773765738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024051909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024051909"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29159","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel GSK3\u03b2 inhibitor 5n attenuates acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29159"}}